Skip to main content

Table 1 Distribution of patients across clinical factors by data set

From: Identification and characterization of alternative exon usage linked glioblastoma multiforme survival

   Training data set Validation data set
   Number Percentage Number Percentage
Patients   250 76.22 78 23.78
Race1 Caucasian 222 88.80 71 91.03
Other 28 11.20 07 8.97
Gender Females 94 37.60 29 37.18
Males 156 62.40 49 62.82
Therapy2 R 63 25.20 21 26.92
CRT 27 10.80 07 8.97
CRnT 99 39.60 31 39.74
OTHER 35 14.00 10 12.82
NONE 26 10.40 09 11.54
Survival (months)   17.46 0.16 - 128 15.02 0.10 – 77.57
  1. 1Race: White Caucasian, and all other race-ethnicity groups.
  2. 2Therapy; R: radiation therapy alone; CRnT: chemotherapy plus radiation and no targeted therapy; CRT: chemotherapy plus radiation and targeted therapy; OTHER: all other therapies; None: no therapy.